Higher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry-s Success in 2012

Five Star Equities Provides Stock Research on Arena Pharmaceuticals and VIVUS

Continue Reading

Iron Ore Industry Experiencing a Resurgence Heading Into 2013

The Paragon Report Provides Stock Research on Rio Tinto and Vale

Continue Reading

Number of Companies Paying Special Dividend Rising Rapidly in 2012 as Dividend Tax Increase Looms

Five Star Equities Provides Stock Research on The Clorox Company and Mattel

Continue Reading

U.S. Oil Demand Falls to a 17-Year Low in October

The Paragon Report Provides Stock Research on Halcon Resources and Magnum Hunter Resources

Continue Reading

Record Production Rates and Decade Low Oil Demand Keeping a Lid on Oil Prices in 2012

The Paragon Report Provides Stock Research on GMX Resources and Lone Pine Resources

Continue Reading

Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases

Five Star Equities Provides Stock Research on Sucampo Pharmaceuticals, Inc. and YM BioSciences Inc.

Continue Reading

Amount of Special Dividend Payments in 2012 Currently Four Times the Amount Seen in 2011

Five Star Equities Provides Stock Research on Microsoft and Paychex

Continue Reading

Iron Ore Industry Looking Strong as Demand From China Expected to Rise Sharply in 2013

The Paragon Report Provides Stock Research on Cliffs Natural Resources and ArcelorMittal

Continue Reading

Special Dividend Payments Increase Fourfold in 2012 as Companies Look to Avoid Upcoming Dividend Tax Increase

Five Star Equities Provides Stock Research on Reynolds American and AT&T

Continue Reading

Mobile Advertising Revenues in the U.S. Projected to Increase to $12 Billion by 2016

The Paragon Report Provides Stock Research on AOL and Yahoo!

Continue Reading